Ca2+/calmodulin-dependent protein kinase II--a target for sodium valproate?

Neurosci Behav Physiol. 2008 Jan;38(1):99-102. doi: 10.1007/s11055-008-0014-2.

Authors

T A Savina¹, O A Balashova, T G Shchipakina

Affiliation

¹ Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, 3 Institutskaya Street, Pushchino, 142290, Moscow Region.

PMID: 18097767
DOI: 10.1007/s11055-008-0014-2

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Animals
Anticonvulsants / pharmacology*
Anticonvulsants / therapeutic use
Brain / drug effects
Brain / enzymology*
Brain / physiopathology
Calcium-Calmodulin-Dependent Protein Kinase Type 2 / drug effects
Calcium-Calmodulin-Dependent Protein Kinase Type 2 / metabolism*
Disease Models, Animal
Enzyme Activation / drug effects
Epilepsy, Reflex / drug therapy
Epilepsy, Reflex / enzymology*
Hippocampus / drug effects
Hippocampus / enzymology
Hippocampus / physiopathology
Inferior Colliculi / drug effects
Inferior Colliculi / enzymology
Inferior Colliculi / physiopathology
Male
Neocortex / drug effects
Neocortex / enzymology
Neocortex / physiopathology
Rats
Rats, Inbred Strains
Valproic Acid / pharmacology*
Valproic Acid / therapeutic use

Substances

Anticonvulsants
Valproic Acid
Calcium-Calmodulin-Dependent Protein Kinase Type 2